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INTRODUCnON
Metabolic changes that occur peripartum allow the dairy cow to partition
nutrients to the mammary gland in excess of dietary energy intake. Zero net energy
balance is not achieved until milk yield is 80 percent of peak yield (about 15 weeks
into lactation)(2). During the first month of lactation, the body reserves utilized is
equivalent to about 33 percent of the milk produced (2). To minimize the energy
deficit, every effort should be made to maximize net energy intake. Various
recommendations to improve energy intake include: minimize environmental stress,
present a balanced diet to the cow in small amounts at frequent intervals, and
increase energy density of the diet. Potentially, another way to reduce energy deficit
is to improve the efficiency of rumen fermentation by addition of ionophores.
As reviewed by Schelling (28), and Bergen and Bates(5), ionophores' most
accepted modes of action include: modification of ruminal VFA profile by
increasing propionate production (27), reducing ruminal methane gas production
(32), decreasing ruminal protein deamination thereby increasing protein utilization
(16) and increasing apparent digestibilities of energy, NDF, and CP (32).
The influence of monensin on performance of finishing cattle has been
summarized by Goodrich et al. (15) using results from about 16,000 cattle.
Monensin fed cattle exhibited a 1.6 percent increased average daily gain, 6.4 percent
decreased dry matter (DM) intake, and 7.5 percent decreased feed/gain. Carcass
characteristics were not affected.
Data showing the effects of monensin on lactating dairy ruminants are
limited. Brown and Hougue (7) reported no change in milk yield, 15 and five
percent reduction in milk fat content, and ten and zero percent increase in milk
protein content when monensin was fed at 33 and 18 ppm, respectively, to dairy
goats during the fourth month of lactation. Feeding monensin four weeks
prepartum increased 4% fat-corrected-milk (FCM) immediately postpartum in dairy
cows (24). Beede et al. (3) reported no changes in milk yield, percent fat or
percent protein in midlactating Holsteins fed lasalocid.
Ionophore supplementation showed no benefits in lactating beef cows
(9,14,21), while others (23,26,31) reported increased feed efficiency. Most
(9,14,21,26) reported trends toward increased milk yield and/or calf weights with
ionophore supplementation. The above trials suggest that ionophores are more
likely to be beneficial when energy intake is restricted or when fed to cows during
early lactation. The purposes of this study were to determine: 1) a minimum
effective dose of monensin, 2) if monensin improves lactational performance in dairy
cows in negative energy balance, and 3) if monensin indirectly affects mammary
lipogenesis or fatty acid uptake.
MATERIALS AND METHODS
Exp. 1—Dose Titration
Two third lactation Holstein cows with approximately the same bodyweight
(BW), stage of lactation, and level of production, were fed a monensin
supplemented diet in an increasing and then decreasing step-wise fashion as follows:
EARLY LATE
Step-up (90 to 118 d postpartum) Step-down (153 to 174 d postpartum)
Week 1 = monensin Week 9 = 450 mg/d
Week 2 = 150 mg/d Week 10 = 300 mg/d
Week 3 = 300 mg/d Week 11 = 150 mg/d
Week 4 = 450 mg/d Week 12 = mg/d
Weeks 5-8 = maintained on high (450-600 mg/d) level of monensin. During this
time, one cow became lame in the rear feet. No data was used during this 4 wk
interval. Both cows were normal when the step-down period started.
Experimental design was a randomized complete block. Data were subjected
to split-plot analysis where whole plot was the level of monensin and the sub-plot
was stage of lactation. Data were analyzed using the General Linear Models
Procedure (20). The statistical model included monensin, cow, (monensin by cow
as the whole plot error) and stage of lactation as the subplot effect. If the subplot
effect was insignificant (P>.1), only main effects are presented. To determine the
effects (P<.1) of monensin, contrasts (linear, quadratic, and cubic) of drug level
were used.
The monensin supplemented grain mix was fed in an automatic feeder with
equal portions fed every two hours. Dry matter intake of the 70:30 cormsoy grain
mix was constant at 10.23 kg/d. Alfalfa hay was limited to approximately 2 kg/d.
Corn silage was fed ad lib. (approximately 6.6 kg DM/d). Forages were fed twice
daily while refusals were collected daily, subsampled, and composited to determine
weekly dry matter intake. Approximate forage:concentrate ratio was 45:55.
Nutrient analysis of feedstuffs and average (avg) diet (percent of DM).
Alfalfa Corn Grain Avg
Item Hay Silage Mix Diet
Dry matter 86.08 43.61 87.39 62.0
Crude protein 20.36 9.19 19.04 15.7
ADF 30.39 24.81 4.52 14.4
Calcium 1.32 .48 .70 .7
Phosphorus .33 .26 .48 .4
Trace mineral salt
.3
Vitamin A (IUxl000/kg) 8.8
Vitamin D (IUxl000/kg) 4.4
Vitamin E (IU/kg) 26.4
Local anaesthesia was used to ruminally fistulate the cows 7 d prior to data
collection. Cows were housed in tie stalls and were allowed to exercise 3 h/d.
Milking time was at 0630 and 1830.
Milk, blood, and rumen samples were collected on Tuesday, Thursday, and
Saturday of each week. Cows were milked with a bucket milker and samples were
collected (a.m. and p.m.) and composited. One sample was used to determine
somatic cell count (SCC), fat, protein, lactose and solids-not-fat (SNF) content at
the Kansas DHIA processing center. A duplicate sample was heated to 80°C for
2 minutes and stored at -20°C (29) until analysis of fatty acid content. Following
a.m. milking, 40 ml of jugular blood was collected in 50 ml heparin coated
disposable syringes equipped with 19 gauge needles. Blood was dispensed into NaF
treated plastic centrifuge tubes. Ten ml of subcutaneous abdominal venous (SAV)
blood was also collected in NaF/K2C204 treated vacutainers. All blood was mixed
and placed on ice for transfer to the laboratory. Blood was centrifuged at 2500 x
g (glass tubes) or at 30,000 x g (plastic tubes). Plasma was subsampled and stored
in 1.5 ml microcentrifuge tubes. Samples for glucose analysis were stored at -20°C.
Plasma (1.4 ml) for insulin and glucagon analysis was treated with 70 ul of
benzamidine (11) and stored at -70°C to minimize any proteolytic activity. Jugular
and SAV plasma was also stored at -70°C for later analysis of lipoprotein lipase
(LPL) activity.
Ruminal contents were mixed, subsampled and strained through 4 layers of
cheesecloth after the a.m. milking. Ruminal pH was measured, 25%
metaphosphoric acid was added to 5% final concentration (10) before freezing at -
20°C for later VFA analysis.
Bodyweights were measured at 1500 on Tuesday and Wednesday of each
week. Weights were averaged for subsequent analysis.
Exp. 2
Eight Holstein cows were supplemented with 200 mg/d of monensin (M) or
no monensin (C) for 3 wk. Cows were adjusted to box stalls, diets, and increased
handling for 9 d before monensin was added to the diet. Monensin
supplementation began 35.6 ± 2.2 d (mean +. SE) postpartum. Cows were paired
by parity and level of production. The experimental design was a randomized
complete block. Data was subjected to split-plot analysis. The whole plot was M
vs. C. The sub-plot was wk of trial. Data were analyzed using the General Linear
Models Procedure (20). The statistical model included treatment, pair (treatment
by pair as the whole plot error) and wk of trial as the sub-plot effect. Weekly
means are presented for both treatments, followed by the SE. To determine the
effects (P<.1) of monensin, contrasts (linear, quadratic, cubic) of wk on trial were
used.
Cows were individually fed a 41:59 foragerconcentrate (100% DM) total
mixed ration 10 percent above ad lib intake twice daily. The total ration was
87.72% DM. A monensin premix (100 mg) was fed after each milking before fresh
feed was dispensed.
Composition of the total mixed ration.
Ingredient % of dry matter
Chopped alfalfa 41.20
Cracked corn 46.97
Soybean meal 7.87
Molasses 2.91
Dicalcium phosphate .29
Calcium carbonate .39
Trace mineral salt .29
Vitamin A. D. and E premix8 .08
aAdded to provide 5433, 3880 and 11 IU/kg of vitamin A, D, and E, respectively.
Nutrient composition of the diet (100% DM basis).
Item Percent of diet
Crude protein 16.41
ADF 17.12
Calcium
.91
Phosphorus
.46
Potassium 1.59
Magnesium J3
Feed analysis was done by LSB Products, Manhattan KS 66502.
Cows were milked at 0930 and 2130 while individual stalls were cleaned and
bedded. Refused feed was collected daily and subsampled to determine daily DM
intake. The table below illustrates trial design and sampling days.
Trial design and sampling days.
Week Week 1 Week 2 Week 3
c c * * I *
*
d= 3,4 8,9 10 15,16 22,23 27,28
c= Fecal examination-negative for coccidia. Dept. of Laboratory
Medicine, Kansas State University College of Veterinary Medicine.
*=Blood, milk, and rumen contents sampled. Bodyweights measured.
| =Start of monensin supplementation.
Milk weights were recorded every milking. Duplicate a.m. and p.m. milk samples
were collected and treated the same as exp. 1. Blood collection was the same as
previously stated. One additional collection of blood was done 5 min after a 5000
IU sodium heparin challenge into the jugular vein 4 h post-milking. Jugular and
SAV blood was collected for analysis of post-heparin releasable lipase activity (30).
Blood handling was the same as described above for lipase analysis.
Rumen contents were collected immediately after a.m. milking with a
stomach tube. Samples were strained, acidified, and frozen for later analysis.
Bodyweights were also measured immediately after a.m. milking.
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LABORATORY PROCEDURES
Two steps were used in determination of fatty acid composition in milk-
total lipid extraction (12) and saponification and re-esterification. These procedures
are detailed by Bitman et al., (6). Heptane was used (instead of hexane) to extract
the fatty acid methyl esters. Separation and analysis of fatty acid methyl esters was
done with a temperature programmed Hewlett-Packard 5890A gas chromatograph
equipped with a 2 mm i.d. x 2 m glass column packed with SP-2330 (Supelco, Inc.,
Bellefonte, PA) on Chromosorb. Column was conditioned overnight at 200°C.
Temperature of the column was held at 120°C for 2 min, then increased at
20°C/min to 160°C, followed by a rate increase of 10°C/min to 185°C (N2 flow rate:
24.4 ml/min; dual flame ionization detectors, detector temp: 250°C; injection port
temp: 235°C). Peak areas were measured with and Hewlett-Packard 3392A
Integrator. Peak identities and quantitative accuracy were determined from known
standards for each fatty acid (Appendix A).
Frozen rumen content samples were thawed, centrifuged, and analyzed for
VFA in a gas chromatograph (17).
Plasma samples were thawed and analyzed for glucose (13), insulin, and
glucagon. Radioimmunoassay kits (Cambridge Medical Technology, Inc., Billerica,
MA 01861) were used to determine insulin and glucagon concentration in plasma.
Glucagon (Lot #258-25J-120) and insulin (Lot #615-70N-80) bovine standards (Lilly
Research Laboratories, Indianapolis, IN 46285) were used to validate the assay
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against the porcine standards provided in the kits. Option III (the supersensitive
protocol) was used on the insulin samples. Glucagon and insulin plasma dilution
curves correlated well (104.15% and 103.53%, respectively) with the bovine standard
curves. The high correlation coefficients achieved while testing linearity indicates
acceptable recovery levels. Sensitivity and 50% binding levels of glucagon and
insulin were 68.56, 875.16, and 75.97, 855.64 pg/ml, respectively. Intraassay and
interassay CV for glucagon and insulin were 12.16, 18.36, 11.30, and 19.00%,
respectively.
Jugular and SAV lipoprotein lipase (LPL) analysis for exp 1 was done at
Michigan State University by J. Liesman, under the supervision of R. S. Emery.
The procedure was performed in our laboratory for trial #2. A radiolabeled
triglyceride (TG) premix was used as a substrate (appendix B). Duplicate plasma
(60 ul) or postheparin plasma (20 ul + 40 ul heat denatured serum (HDS) was
mixed with 40 ul of 3% BSA (0.15M NaCl pH 7.4), and 100 ul of TG premix.
Blank (60 ul HDS), control, fatty acid recovery (100 ul of fatty acid premix or 50
ul of fatty acid premix + 50 ul 8% BSA replaced the 100 ul of TG premix), and
quench (100 ul of 8% BSA replaced the TG premix) tubes were also included in
each assay. All tubes were incubated at 39°C for 1 h in a shaking water bath. To
stop LPL activity, 1.64 ml of heptane:methanol:chloroform (1:1.41:1.25) and 0.425
ml of alkaline buffer (1.266% K2B4 7-4 H20, 2.756% K2C03) was added to all tubes
on ice. Tubes were then mixed for 15 s, and centrifuged (20°C, 2500 x g, 15 min)
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for phase separation to occur. The supranatant (0.5 ml) was dispensed into
scintillation vials followed by the addition of 10 ml of scintillation fluid (Bio-Sage
II, cat. No. 111195, Research Products International Corp., Mount Prospect, IL
60056-2190). Triglyceride and fatty acid premix (10 ul) was added to the
appropriate quench vials immediately prior to the addition of 0.5 ml of quench
supranatant and scintillation fluid to make the appropriate standards. The
calculations used to determine the FA recovery factor, nmol FA/DPM and nmol
FA/tube are in appendix C. The average FA recovery in the supranatant was
26.56%. Precision was acceptable based on the linearity of the graphs in figures 1
and 2. Intraassay and interassay CV were 5.53 and 10.33%, respectively. Specificity
was proven by quantitative inhibition of enzyme activity by 1 M NaCl, in
combination with serum stimulation and an optimum alkaline pH (22).
RESULTS AND DISCUSSION
Results from exp. 1 and #2 are in tables 1 to 8. The format of table 1 to
4 illustrates the trends that are seen with increasing levels of monensin. If the
stage of lactation influenced (P<.1) the effect of monensin, both early and late
stages are presented. Monensin elicited most of its effects during the initial (150
mg) level. Therefore, monensin levels 150 to 450 mg/d were averaged (table 1).
The percent change from level is also presented. Table 5 to 8 includes weekly
means, the average value of each trait during the three wk of monensin
supplementation, the percent change from the initial week (wk 0=no monensin
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supplementation), and the net affect of monensin. Most of the effects of monensin
were elicited before wk 2 of trial 2, which partially justifies combining wk 1-3.
Increased milk yield with monensin supplementation has only been shown in
one other study (24), when monensin (100 mg) was supplemented to friesian cows
4 wk prepartum to parturition. Other studies previously mentioned showed no milk
response to ionophores in mid to late lactating does (7) and cows (3). The
consistent response in both trials (6.3 and 7.4%) (tables 1 and 5) suggest that
monensin supplementation might be most beneficial during the early lactation
energy deficient state. Additional information from exp. 2 is included in figure 3.
Weekly means of daily milk production for the eight cows are plotted through the
first 12 wk of lactation. The filled arrows indicate the beginning and end of
monensin supplementation. The open arrows indicate the same corresponding
period for C. Despite blocking by parity and level of production, there was a
difference in pretreatment production levels. Within one week after monensin
supplementation, M equalled C and surpassed C by 2 wk post-supplementation.
Treated cows maintained the edge through the trial. By 3 wk after the trial, M
returned back to the same production level relative to C.
The tendency for decreased fat content and yield (-8.6 and -2.8% for exp. 1,
and -8.5 and -1.1% for exp. 2, respectively) (tables 1 and 5) agree with others
(3,7,24). Armstrong and Blaxter (1) measured a 15% reduction and a 12% increase
in milk fat and nitrogen content, respectively, with ruminal propionate infusion at
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10% of metabolizable energy requirement in does. Brown and Hougue (7) reported
an increase in milk protein content in does only when intake was restricted at
neutral energy balance. No change in protein content was seen in midlactating
Holsteins fed lasalocid (3). Exp. 1 results show increased milk protein content and
yield in early lactation but lower protein content while maintaining daily output in
later lactation. Milk protein content did not change during monensin
supplementation in exp. 2, but due to higher milk yield, protein yield also increased
(tables 1 and 5). The somewhat contradictory results in these trials and past
experiments can be explained by the differences in energy status of the cows. In
exp. 1, the cows were near the end of the negative energy stage during the step-
up period (according to Bauman and Currie (2), zero net energy balance is not
achieved until 15 wk or about 105 d postpartum) which ended 118 d after
parturition. In exp. 2, all cows were at peak lactation but prior to peak intake.
Therefore, the order of energy balance (from lowest to highest) is the cows in:
l)exp. 2, 2)exp. 1-early, and 3)exp. 1-late. During negative energy status,
gluconeogenesis from protein is occurring causing a deficiency of amino acids
available for milk synthesis. Monensin has been shown to increase nitrogen
absorption as a result of lower microbial degradation of feed protein (4). Monensin
supplementation also results in increased ruminal propionate which, in theory,
causes increased gut usage of propionate, thereby increasing portal supply of glucose
(18). Therefore, monensin increases portal supply of glucose and amino acids,
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which indirectly increases the supply of substrate needed for milk and protein
synthesis. Consequently, the most energy deficient group (exp. 2) responded with
no change in milk protein content (+0.2%), but still increased protein output
(+10.1%) (table 5); while the cows in exp. 1 during the early stage responded with
increased protein content and yield (+8.5 and +14.9%, respectively) (table 1).
After positive energy balance is achieved, monensin had no affect on milk protein
content (-7.9%) (it is normal for protein content to increase as lactation
progresses)(19) and a slight affect on yield (-1.8%) (as a result of maintaining milk
yield).
Monensin supplementation did not have a significant affect on fatty acid
composition of milk. Based on the control cows in exp. 2, the fatty acid
composition of milk shifts to a larger ratio of short chain fatty acids (SCFA)
(shorter than C16):long chain fatty acids (LCFA) (longer than C16) (i.e. 0.58 to
0.96) as lactation progresses (table 6). During early lactation, adipose tissue is
depleted because of the high energy requirement for milk production beyond the
amount supplied by the diet. Adipose tissue fatty acids are mobilized into the
bloodstream allowing the mammary gland to incorporate those LCFA of body origin
into milk triglycerides. Hence, the high level of LCFA in early lactation milk. After
dry matter intake peaks and milk yield begins to decline, adipose tissue is repleted
resulting in less preformed fatty acid absorption by the mammary gland. There was
no net effect of monensin on SCFA (-2.2%) or LCFA (+7.6%) in exp. 2 (table 6).
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The significant increase (+16.7%) in SCFA and decrease (-11.1) in LCFA in milk
during the early portion of exp. 1 (table 2) is partially due to advancing lactation
as was observed by Chillard et al. (8), who reported decreased LCFA, and increased
SCFA and C16 between 1 and 7 wk postpartum. There is a tendency to theorize
that monensin may have a positive affect on SCFA content in milk during early
lactation. There is insufficient evidence to prove that effect, but the plasma LPL
data on the early cows in exp. 1 correlate with the milk fatty acid results.
Mammary minus jugular LPL activity decreased 45.2% (table 4) which indicates less
LCFA uptake capacity by the mammary gland. However, lack of change of
mammary minus jugular LPL (-0.1%) in exp. 2 leaves this theory in doubt (table 8).
The large decrease in mammary minus jugular postheparin plasma LPL activity (-
70.4%) is unexplainable, especially when no concomitant change occurred in fatty
acid composition or plasma lipase activity.
Monensin supplementation did not have a consistent affect on plasma insulin
or glucagon (tables 4 and 8). Glucagon tended to decline (0.1 ng/ml) during high
doses of M (450 mg/d) in exp. 1, but did not change relative to C on cows in exp.
2. Plasma insulin increased (+14.6%) in exp. 2, but did not change (-3.3%) in exp.
1. Harmon and Avery (18) reported no change in plasma arterial insulin
concentration when monensin (220 mg/d) was fed to Holstein steers on an 85%
concentrate diet.
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Plasma glucose in cows fed M did not change relative to C in exp. 2 (table
8), but tended to increase as lactation progressed (3.19 to 3.40 mM). There was
an unexplainable stage by level of monensin interaction in exp. 1. Plasma glucose
tended to decline (-0.6%) as dosage increased in the early phase, while increasing
in the later stage (+2.2%) (table 4). Due to tight homeostatic mechanisms,
insulimglucagon ratios did not change (+3.9 and +0.9% in exp. 1 and #2,
respectively). Harmon and Avery (18) demonstrated an increase in net portal flux
of glucose with monensin supplementation. Inconsistency in the results of trials #1
and #2 for glucose, insulin, and glucagon concentrations may be caused from
measuring venous plasma concentrations.
Monensin supplementation did not significantly affect dry matter intake in
either trial (+13.2 and -1.8%) (tables 3 and 7) which agrees with Bergen (1984)
who stated ionophores do not depress intake on high forage diets. Efficiency
(4%FCM/DMI) decreased in both M and C groups (-9.0 and -14.7%) in exp. 2 as
expected with advancement of lactation, but the net effect of monensin tended to
be positive (+5.7%) (table 7).
The fact that monensin increases ruminal propionate concentration is well
documented. Both trials support that fact with net increases of 16.4 and 10.7% in
exp. 1 and 2, respectively (tables 3 and 7). Isobutyrate is the only other VFA that
tended to be affected (+11.1 and +8.1%) by monensin supplementation.
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CONCLUSIONS
Evidence from these trials indicate that monensin supplementation at low
levels may be economically beneficial to use in lactating cow diets. Many of the
results presented are inconclusive due to the low number of experimental units.
Additional research is necessary before monensin supplementation can be
recommended for commercial use.
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Table 1. Effect of level of monensin on various milk traits.
Level of monensin Cme/d") Average Effect of
Trait Stage
_0_ 150
—Least S
300
quare Means
450
SE
level
150-450
monensin
Milk
Yield (yld) (kg/d)2 18.9 20.0 20.2 20.1 0.3 20.1 + 63
Fat (%) 3.88 3.48 3.59 3.57 0.09 3.55 -8.6
Fat (kg/d) 0.72 0.69 0.71 0.70 0.03 0.70 -IS
4% FCM (kg/d) 1836 1836 18.68 18.55 0.61 18.53 + 0.9
SCM (kg/d) 17.27 17.45 17.77 17.63 0.59 17.62 + 2.0
Lactose (%) 4.43 4.40 4.44 4.45 0.02 4.43 0.0
Protein (%)* Early 2.80 3.00 3.04 3.07 0.07 3.04 + 8.5
Late 3.24 3.04 3.00 2.91 0.07 2.98 -7.9
Protein (kg/d) 1 Early 0.56 0.64 0.65 0.64 0.01 0.64 + 14.9
Late 0.57 0.56 0.56 0.56 0.01 0.56 - 1.8
SNF(%) 7.97 7.98 8.02 8.01 0.04 8.00 + 0.4
SNF (kg/d) 1.50 1.59 1.60 1.60 0.04 1.60 + 6.4
SCC (xlOOO/ml) 460 493 382 354 57 410 -10.9
*Stage x level of monensin interaction (P<.1)
^Monensin effect linear (P<.1).
Table 2. Effect of level of monensin on milk fat characteristics.
Trait
Milk fatty acids
C8(%)
Stage
(% of total
Level of monensin fmg/d)
150 300
Least Square Means
fat)
2.83 2.92 3.06
450
3.19
SE
0.20
Average
level
150-450
3.06
Effect of
monensin
(%)
+ 8.0
CIO (%) 4.55 4.76 4.% 4.93 0.18 4.88 + 73
C12 (%)a Early
Late
4.41
5.23
5.40
5.06
5.85
4.97
5.72
4.89
0.20
0.20
5.66
4.97
+28.3
-4.9
C14 (%)! Early
Late
12.78
14.56
13.92
14.24
14.98
14.04
14.22
13.69
0.18
0.18
1437
13.99
+12.5
-3.9
C16 (%)! Early
Late
33.99
32.61
35.50
31.88
34.78
30.89
32.42
31.08
033
0.33
34.23
31.28
+ 0.7
-4.1
C16:l (%) 2.92 2.92 2.90 2.76 0.19 2.86 -2.1
C18 (%) 12.27 11.22 10.58 10.99 0.58 10.93 -10.9
C18:l (%)! Early
Late
2230
2233
20.29
24.40
19.57
26.04
22.81
25.48
0.58
0.58
20.89
25.31
-63
+133
C18:2(%) 333 2.82 2.95 2.97 0.21 2.91 -12.5
Short chain fatty adds 1
C8 + C10 + Early
C12 + C14 Late
Long chain fatty adds 1
C18 + C18:l + Early
C18:2 Late
24.20 26.94 29.11 28.65 0.79 28.23 + 16.7
27.54 27.05 26.78 26.09 0.79 26.64 -33
38.84 34.42 33.16 36.03 0.89 34.54 -11.1
36.98 3836 39.50 40.19 0.89 3935 + 6.4
^Stage x level of monensin interaction (P<.1).
^Monensin effect linear (P<.1).
Table 3. Effect of monensin on bodyweight, feed intake, and ruminal parameters.
Trait Stage
Bodyweight (kg)
Level of monensin Cmg/d"
150 300
Least Square Means
509 530 568
1
450
565
SE
32
Average
level
150-450
554
Effect of
monensin
(%)
+ 8.9
Dry matter intake (kg/d) 15.1 15.7 18.1 175 1.7 17.1 + 13.2
Ruminal
PH 5.60 5.99 632 6.27 035 6.19 + 10.6
Acetate (mM) 68.8 69.9 70.9 69.8 2.0 70.2 + 2.0
Propionate (mM)^ 21.1 23.6 23.6 265 0.8 24.6 + 16.4
AcetateiPropionate^ 333 3.00 3.05 2.68 0.5 2.91 -12.6
Butyrate (mM) 14.1 13.8 153 13.8 0.8 143 + 1.4
Isobutyrate (mM) 1.29 1.30 1.53 1.47 0.07 1.43 + 11.1
Valerate (mM) 1.39 1.42 1.49 1.45 0.07 1.45 + 4.6
Isovalerate (mM) 2.36 2.34 2.68 2.46 0.20 2.49 + 5.7
Total VFA (mM) 108.7 113.0 115.2 115.8 3.6 114.7 + 55
^Stage x level of monensin interaction (P<-1).
^Monensin effect linear (P<.1).
Table 4. Effect of monensin on various plasma parameters.
Level of monensin (rneJd) Average Effect of
150 300 450 level monensin
Trait Stage
Plasma
SE 150-450 (%)
Insulin (ng/ml) 0.82 0.81 0.76 0.81 0.05 0.79 -33
Glucagon (ng/ml)^ 0.97 0.95 0.97 0.86 0.03 0.93 -45
Insulin:Glucagon ratio 0.85 0.88 0.79 0.98 0.06 0.88 + 3.9
Glucose (mM)1 Early 356 3.60 3.60 3.42 0.04 354 -0.6
Late 339 3.41 3.41 3.57 0.04 3.46 + 2.2
Plasma LPL (nMol FA released/h/ml)
Mammary Early 1271 874 703 653 169 743 ^»15
Late 764 837 766 794 169 799 + 4.6
Jugular Early 231 191 161 170 24 174 -24.7
Late 170 201 180 155 24 179 + 5.1
Mammary-Jugular Early 1040 684 542 483 147 570 -45.2
Late 595 636 586 639 147 620 + 4.3
'Stage x level of monensin interaction (P<.1).
^Monensin effect linear (P<.1).
Table 5. Effect of monensin on various milk traits.
Treat-
ment
M2
C
Week of trial
_3_
ns--
39.4
38.7
SE
1.0
1.0
Change
Average from
Wk 1-3 wk (%)
38.7 +10.9
38.3 + 3.5
Net
Trait
Milk
Yield (yld)*
(kg/d)
_p_
-Least
34.9
37.0
Square Mea
36.9 39.7
37.5 38.7
effect of
monensin (%)
+ 7.4
4%FCM
(kg/d)
M
C
32.5
34.7
33.6
35.5
32.2
33.5
33.7
33.5
1.2
1.2
33.2
34.2
+ 2.2
- 1.4
+ 3.6
Fat
(%)
M
C
3.48
3.51
3.13
3.56
2.84
3.25
2.96
3.10
0.09
0.09
2.98
3.30
-14.4
-5.9
-8.5
Fat yld2
(kg/d)
M
C
1.23
1.31
1.21
1.35
1.11
1.22
1.18
1.20
0.05
0.05
1.17
1.26
-4.9
-3.8
- 1.1
Protein
(%)
M
C
3.00
3.08
2.89
2.92
2.83
2.92
2.88
2.99
0.04
0.04
2.87
2.94
-4.3
-4.5
+ 0.2
Protein yld
(kg/d)
M
C
1.05
1.16
1.11
1.11
1.10
1.10
1.15
1.15
0.04
0.04
1.12
1.12
+ 6.7
-3.4
+ 10.1
sec
(x 1000/ml)
M
C
125
94
136
84
68
61
84
86
28
28
96
77
-23.2
-18.1
-5.1
'Mean is calculated from all days in week. All other traits were measured during the final two days
of each week.
treatment x wk interaction (P<.1).
2Weekly effect is linear (P<.1).
3Weekly effect is quadratic (P<.1).
Table 6. Effect of monensin on milk fat characteristics.
Week of trial Change Net
Treat-
_0_ _1_ J2_ _3_ Average from effect of
Trait ment --Least Square Means- SE Wk 1-3 wk (%) monensin (%)
Milk fatty acids (% of total fat)
C82 M 3.42 3.30 3.42 4.60 0.16 3.77 +10.2 + 1.2
(%) C 3.67 3.43 3.79 4.79 0.16 4.00 + 9.0
CIO2 M 3.82 4.14 4.19 4.82 0.16 4.38 +14.7 + 0.8
(%) C 4.11 4.11 4.65 5.28 0.16 4.68 +13.9
C122 M 3.95 4.39 5.03 5.46 0.18 4.96 +25.6 - 5.1
(%) C 4.14 4.33 5.62 6.27 0.18 5.41 +30.7
C142 M 11.75 12.44 13.32 13.07 0.31 12.94 +10.1 - 3.4
(%) C 11.65 12.45 13.38 13.82 0.31 13.22 +13.5
C162 M 32.59 34.40 35.12 34.71 0.81 34.74 + 6.6 - 7.2
(%) C 31.58 34.25 37.24 36.37 0.81 35.95 +13.8
C16:l2 M 4.89 3.83 3.14 2.25 0.26 3.07 -37.2 - 6.9
(%) C 3.99 3.49 2.73 2.11 0.26 2.78 -30.3
C182 M 11.26 9.03 8.27 8.95 0.69 8.75 -22.3 - 5.8
(%) C 11.79 10.95 9.61 8.99 0.69 9.85 -16.5
C18:l : M 24.93 24.27 23.73 22.39 0.63 23.46 - 5.9 +13.1
(%) C2 24.73 22.71 19.00 18.36 0.63 20.02 -19.0
C18:2 M 2.71 2.83 3.05 3.01 0.10 2.96 + 9.2 + 9.8
(%) C 3.25 3.38 3.14 3.16 0.10 3.23 - 0.6
C18:3 M 0.67 0.85 0.73 0.77 0.06 0.78 +16.4 +28.3
(%) C 1.01 0.89 0.94 0.85 0.06 0.89 -11.9
Short chain fatty acids2
C8+C10+ M 22.94 24.27 25.96 27.95 0.49 26.06 +13.6 - 2.2
C12 + C14 C 23.58 24.33 27.43 30.16 0.49 27.31 +15.8
Long chain fatty acids2
C18+C18:l M 39.57 36.97 35.78 35.12 1.20 35.96 - 9.1 + 7.6
C18:2+C18:3 C 40.78 37.92 32.69 31.36 1.20 33.99 -16.7
treatment x wk interaction (P<.1).
2Weekly effect is linear (P<.1).
3Weekly effect is quadratic (P<.1).
Table 7. Effect of monensin on bodyweight, feed intake and ruminal parameters.
Treat-
ment
M
C
Week of trial
_3_
ns-
23.1
25.3
SE
0.8
0.8
Change
Average from
Wk 1-3 wk (%)
22.4 +13.1
24.5 +14.9
Net
Trait
Dry matter*2
intake (kg/d)
_p_
-Least
19.8
21.3
A. JL
Square Mea:
21.6 22.6
23.0 25.1
effect of
monensin (%)
- 1.8
Bodyweight2
(kg)
M
C
580
565
586
562
598
580
603
586
5
5
596
576
+ 2.8
+ 1.9
+ 0.9
Adjusted2
intake(%BW)
M
C
3.52
3.98
3.86
4.30
3.81
4.28
3.93
4.37
0.11
0.11
3.87
4.32
+ 9.9
+ 8.5
+ 1.4
Efficiency2 M
(4%FCM/DMI)C
1.55
1.56
1.40
1.38
1.41
1.33
1.43
1.28
0.06
0.06
1.41
1.33
-9.0
-14.7
+ 5.7
Ruminal
Acetate1
(mM)
M3
C
55.5
55.7
47.7
58.7
50.7
57.0
62.2
51.8
4.1
4.1
53.5
55.8
-3.6
+ 0.2
-3.8
Propionate2
(mM)
M
C
19.2
18.3
20.7
18.8
24.7
23.3
27.8
21.8
1.8
1.8
24.4
21.3
+27.1
+16.4
+10.7
Butyrate
(mM)
M
C
9.69
9.18
9.05
10.02
8.66
8.60
11.43
9.40
0.94
0.94
9.71
9.34
+ 0.2
+ 1.7
- 1.5
Isobutyrate
(mM)
M
C
1.15
1.29
1.02
1.29
1.03
1.08
1.25
1.01
0.11
0.11
1.10
1.13
-4.3
-12.4
+ 8.1
Valerate
(mM)
M
C
1.24
1.12
1.20
1.17
1.36
1.28
1.60
1.23
0.12
0.12
1.39
1.23
+12.1
+ 9.8
+ 2.3
Isovalerate
(mM)
M
C
1.60
1.68
1.54
1.74
1.42
1.38
1.83
1.34
0.19
0.19
1.60
1.49
0.0
-11.3
-11.3
Ac:Pro
ratio
M
C
3.07
3.12
2.52
3.18
2.23
2.50
2.39
2.55
0.65
0.65
2.38
2.74
-22.5
-12.2
-10.3
Total VFA1
(mM)
M2
C
88.42
87.30
81.18 87.86 106.12
91.69 92.62 86.49
6.07
6.07
91.72
90.27
+ 3.7
+ 3.4
+ 0.3
'Mean is calculated from all days in week. All other traits were measured during the final two days
of each week.
treatment x wk interaction (P<.1).
2Weekly effect is linear (P<.1).
3Weekly effect is quadratic (P<.1).
Table 8. Effect of monensin on various plasma parameters.
Week of trial Change Net
Treat-
_0_ _1_ _2_ _3_ Average from effect of
Trait ment -Least Square Means- SE Wk 1-3 wk (%) monensin (%)
Plasma
Glucose2 M 3.19 3.33 3.41 3.30 0.07 3.35 + 5.0 - 2.8
(mM) C 3.19 3.34 3.50 3.49 0.07 3.44 + 7.8
Insulin2 M 0.55 0.62 0.64 0.65 0.03 0.64 +16.4 +14.6
(ng/ml) C 0.57 0.57 0.59 0.58 0.03 0.58 + 1.8
Glucagon M 1.32 1.37 1.45 1.44 0.09 1.42 + 7.5 + 2.1
(ng/ml) C 1.68 1.67 1.89 1.76 0.09 1.77 + 5.4
Ins:Glucagon M 0.49 0.49 0.47 0.48 0.03 0.48 - 2.0 + 0.9
ratio C 0.34 0.34 0.31 0.33 0.03 0.33 -2.9
Plasma LPL (nMol FA released/h/ml)
Mammary2 M 964.5 770.2 765.7 801.8 88.6 779.2 -19.2 - 0.9
C 1167.3 961.0 981.4 919.1 88.6 953.8 -18.3
Jugular M 281.2 243.0 264.4 252.6 31.6 253.3 - 9.9 - 2.9
C 336.6 295.8 319.9 323.2 31.6 313.0 - 7.0
Mammary - M 683.3 527.2 501.3 549.2 64.7 525.9 -23.0 - 0.1
Jugular C 830.6 665.1 661.5 595.9 64.7 640.8 -22.9
Posthcparin plasma LPL (uMol FA released/h/ml)
Mammary M 42.33 26.99 33.03 35.21 3.79 31.74 -25.0 -21.8
C 41.34 36.89 41.51 40.67 3.79 39.69 - 4.0
Jugular M 34.03 23.38 32.75 33.04 3.62 29.72 -12.7 - 8.9
C 35.87 31.14 37.13 35.22 3.62 34.50 - 3.8
Mammary - M 8.30 3.61 0.28 2.17 2.51 2.02 -75.7 -70.4
Jugular C 5.48 5.75 4.38 5.45 2.51 5.19 -5.3
treatment x wk interaction (P<.1).
2Weekly effect is linear (P<.1).
3Weekly effect is quadratic (P<.1).
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Metabolic Changes of the Periparturient Bovine
J. C. Kube, J. E. Shirley, D. L. Harmon, and R. A. Frey
INTRODUCTION
Parturition and the initiation of lactation are two physiological states that
require enormous redirection of nutrient flow in order to meet the added metabolic
requirements (2). To better define the requirements during these conditions,
researchers must understand the controlling mechanisms of parturition and
lactogenesis.
Normal hormonal (and enzymatic) changes associated with parturition and
initiation of lactation have been reviewed (1,6,8,11,15,29,33,34,36). By understanding
endocrine changes that occur peripartum, lactation has been successfully reinitiated
in hypophysectomized does (9) and induced in 7.5 mo pregnant heifers (35).
Induction of parturition is easily performed in various species with high predictability
and few complications, but milk yield has been less than normal.
Despite modest success with induction of lactation and parturition,
understanding the homeorhetic mechanisms that are responsible for the shift of
nutrient flow from body maintenance, to the fetus, and finally to the mammary
gland are necessary for further advancements to be made. One organ that appears
to dictate the direction of nutrient flow is the mammary gland. To understand the
extent of control the mammary gland has on body metabolism, one must determine
whether the nutrient redistribution associated with lactation is due to enhanced
mammary gland activity and milk removal, to hormonal changes associated with
parturition, or both. The objective of this experiment was to determine if selected
metabolic and hormonal changes normally associated with parturition and initiation
of lactation result from parturition, lactation, or both.
MATERIALS AND METHODS
Eleven Hereford x Angus cows were bilaterally mastectomized (M) during
the sixth to seventh month of their second gestation at the Department of Surgery
and Medicine, Kansas State University College of Veterinary Medicine. Fourteen
normal Hereford x Simmental multiparous cows were controls (C). Blum et al.
(4) stated that the effect of breed (Simmental, Brown Swiss, Holstein, or Holstein
x Simmental) on blood parameters is rarely significant. All cows were group fed 4.5
kg (starting 1 mo prepartum until parturition) or 6.8 kg (from parturition until 2 mo
postpartum) cracked corn-soy concentrate plus ad lib sorghum silage. Jugular and
subcutaneous abdominal venous (SAV) blood samples were collected between 0900
and 1100 on -30, -5, -4, -3, -2, and -1 d from expected calving date and 0, 1, 2, 3,
4, 5, 10, 15, 21, 25, 30, and 55 d from actual calving date. Subcutaneous adipose
tissue samples were collected -21 and -5 d from expected calving date and 5, and
21 d from calving. An additional adipose tissue sample was collected 55 d
postpartum on M. Calves were weaned from C on 28 d postpartum.
Experimental design was a completely randomized design with repeated
measures over time. Data were analyzed using the General Linear Models
Procedure (19). Whole plot (M vs. C) effects were determined with cow within
treatment as the error term. Whole plot SE are included in the results. To
determine if treatments are different (P<.05) at a particular point, multiply the SE
by 4. If the difference between the two points is greater that sum, then the
difference is significant (P<.05).
All cows were fully recovered from the mastectomy surgery prior to sample
collection. Jugular and SAV blood was collected, transported to the laboratory in
an ice bath, and processed for later analysis of lipoprotein lipase (LPL), glucose,
insulin (INS), and glucagon (GLUCAG) identical to the procedure described in part
I of this thesis. Plasma samples that were stored for analysis of Cortisol (CORT),
thyronine (T3), thyroxin (T4), and prolactin (PRL) were processed the same as the
samples to be analyzed for glucose. Subcutaneous adipose tissue was taken by
surgical biopsy 20 cm lateral to midline in the loin area(29). The biopsy site was
clipped, scrubbed, and anesthetized with 7 ml of Lidocaine-HCl. A 4 cm incision,
parallel to the spine, was made and approximately 1 gm of adipose tissue was
excised. The tissue was immediately placed in 0.15 M KC1 (5°C) and transported
to the laboratory on ice. The incision was sutured with no. 1 VetafH. Subsequent
samples were collected from the opposite loin area as well as both sides of the
dorsal shoulder region 20 cm lateral to the midline. In the laboratory, the adipose
tissue was rinsed with 0.15 M KC1 through 4 layers of cheesecloth and blotted dry
to remove blood. Samples were placed in labeled twirl packs and stored at -70°C
until further analysis.
Laboratory procedures for plasma analysis of glucose, INS, and GLUCAG
are described in part I. These samples were pooled with the samples from part I
of thesis for analysis, therefore, performance data is the same. Radioimmunoassay
kits (Cambridge Medical Technology, Inc., Billerica, MA 01861) were also used to
determine plasma CORT, T4, and T3 concentrations. The kits were previously
evaluated against bovine standards as explained in the protocol included with the
kits. Sensitivity levels of CORT, T4, and T3 were 1.4 ng/ml, 0.5 ng/ml, and 54.7
pg/ml, respectively. Intraassay and interassay CV for CORT, T4, and T3 were 14.92
and 15.35%, 6.75 and 12.60%, and 7.51 and 8.78%, respectively. Evaluation of
plasma PRL was performed at Michigan State University under the supervision of
H. A. Tucker. Sensitivity level of PRL was 0.3 ng/ml at 90% binding. All samples
were evaluated in a single assay, with intraassay CV = 8.35%.
Jugular and SAV LPL analysis has been described in part I. Adipose tissue
LPL protocol is identical to the plasma protocol. See appendix D for the
description of tissue preparation for LPL analysis (29). The filtrate was used for
protein determination and lipolytic activity. Adipose tissue LPL activity is expressed
as the amount of fatty acids released/(hmg) protein. Intraassay CV (all samples
were run in one assay) for adipose tissue LPL was 10.14%. Precision was
acceptable and lipolytic activity remained constant through 90 min (figure 1). An
incubation time of 60 min with a filtrate vol of 60 ul was identical to the time and
vol used on the plasma. Average FA recovery was 29.23%. Protein concentration
of the filtrate was determined with BCA Protein Assay kit (Pierce, Rockford, IL
61105) (31). The standard protocol was followed using BSA to make 6 standards
ranging from 200 to 1200 ug/ml of protein. Diluent used was 0.15M KC1.
Intraassay and interassay CV of protein content was 4.39 and 5.80%, respectively.
RESULTS AND DISCUSSION
All parameters measured are illustrated in graphic form (figures 2-19).
Within each measurement, there are two graphs. The top graph shows weekly
changes from 7 wk before through 8 wk after parturition. Data on the control cows
were collected through -3 through 5 wk only. The bottom graph shows daily
changes from 15 d before through 15 d after parturition. Mastectomized cows were
artificially inseminated, while C were naturally serviced. Therefore, calving dates
on M were more accurate, allowing more precise data collection prior to calving (no
samples taken -15 to -10 d prepartum). Standard error bars represent whole plot
SE.
Glucose
Glucose levels were higher in the M the week of, through 3 wk after
parturition (figure 2). Weaning the calves from C tended to increase plasma
glucose levels to that of M. The daily trend of glucose concentration around
parturition is similar between groups (figure 3). However, plasma glucose is higher
in M on -1, 1, 2, 3, 4, and 5 d form calving. Davis et al. (11) (doe) and Vaios and
Phillips (36) (cow) both report similar increases in plasma glucose 1 d prepartum
and return back to normal 1 d postpartum. The reason for the elevated glucose
levels in M may be from lack of glucose uptake by the mammary gland. Davis et
al. (11) measured increased mammary glucose uptake starting 2 d prepartum,
continuing through parturition and lactation. The triggering mechanism for
increased glucose uptake is the precipitous drop in plasma progesterone
concentration 2 d prepartum. Progesterone blocks lactose synthetase function to
convert glucose + UDP-galactose — lactose (Stevenson personal communication,
1988). Therefore the overall elevation of plasma glucose in M is a result of gland
removal, however, the glucose spike at parturition is independent of lactogenesis
and may be a result of epinephrine release at parturition.
Insulin
Plasma INS levels tend to be elevated in M through parturition until 2 wk
postpartum (figure 4) then returns to prepartum levels by 2 wk postpartum.
Beginning 1 wk prepartum, INS concentration increased and remained high
throughout data collection in C. In contrast, deBoer et al. (12) reported a decrease
in plasma INS between measurements at 2 wk prepartum and 3 wk postpartum in
Holsteins. Blum et al. (5) also found an insignificant numerical decrease in plasma
INS from 3-4 wk prepartum to 3-4 wk postpartum in Jerseys. Insulin concentration
spiked upward in both groups on the day before parturition (figure 5). A similar
surge was reported by Chew et al. (6) in dairy cows, but the surge began the day
of calving. Plasma INS remained significantly higher in M through 4 d after calving.
Malven et al. (21) recorded an increase in arterial INS from -7 to -4 d, then
decreased at a constant rate until 4 d postpartum. Concurrently, blood flow to the
mammary gland was lowest on -4 d, and highest on 4 d from parturition. Malven
et al. (21) concluded that net mammary uptake of INS changed very little from -7
d to 6 d from calving.
The somewhat contradictory results between this and past trials could be
due to the animals studied. Beef cows have not been intensely selected for milk
production like dairy animals. Also, the calves from C did not remove all the milk
from their dams during the first days after birth. This incomplete milk out may
have influenced blood flow and INS (and glucose) uptake by the mammary gland,
which could result in higher plasma INS and glucose concentrations. Another
possibility for increased levels of plasma glucose and INS may be from the increased
energy level of the diet fed after calving.
Glucagon
Plasma GLUCAG was elevated in M from -1 to 3 wk from parturition
(figure 6). Controls tended to have lowest GLUCAG levels -4 to 4 d from calving,
but surged at -3 d and returned to the prepartum low level by 1 d from calving
(figure 7). A subtle surge was also detected in M at -4 d, continued increasing
until 4 d from calving, then leveled off. Increased GLUCAG is a gluconeogenic
signal to the liver to increase plasma glucose levels (13), thereby causing increased
INS levels as was seen in previous figures.
InsuIin:glucagon ratio
Plasma INS:GLUCAG ratio was higher in M -3 wk and continued to be
numerically higher through 2 wk from parturition (figure 8). The general pattern
of changes was similar between groups. Daily INS:GLUCAG levels mimicked one
another very closely (figure 9). Both groups displayed a downward surge beginning
-3 d and reached a nadir -2 and -1 d from calving in M and C, respectively.
Controls peaked on d and dropped precipitously until 3 d from calving, while M
tended to remain at a relatively lower peak than C from to 3 days from calving-
-after which levels dropped until 5 d postpartum. Because of strict homeostatic
control, INS:GLUCAG ratio illustrated very similar patterns. Parturition itself is
responsible for the major changes of these hormones, with lactation having a
secondary effect. Lack of lactation in M tended to cause a lag in recovery of
hormones back to prepartum levels mainly due to the absence of a milk synthesis
drag.
Cortisol
Plasma CORT levels were higher throughout the periparturient period in M.
Periphery levels of CORT were significantly higher in M at -3 wk and declined at
a faster rate than C until 1 wk from parturition (figure 10). Both groups tended
to increase in CORT until 3 wk, then merged together by 5 wk from calving
(possibly due to weaning the calves from C). Daily CORT levels were also higher
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in M. Inconsistent surges began -4 d and continued 3 d from parturition in both
groups (figure 11).
Glucocorticoid (GCC) is considered to be one of the lactogenic hormones,
except in rabbits. Its functions include playing roles in differentiation of rough
endoplasmic reticulum and golgi apparatus (23). In late gestation, mammary cell
receptors for GCC increase, and competitive binding of progesterone on GCC
receptors is removed (Stevenson personal communication, 1988). Cortisol binding
globulin also decreases peripartum, allowing increased metabolically active free GCC
(34). Increased binding of plasma GCC to mammary gland receptors may explain
the decrease in plasma Cortisol concentration immediate prepartum and shortly
postpartum. The lack of mammary receptors in M may explain the elevated CORT
levels throughout the collection period. The surge of CORT around parturition is
similar to Smith et al. (30), only the spike of CORT at parturition was more distinct
in their study. They (30) conclude that it is not known whether the surge at
parturition is necessary for lactogenesis or whether it is stress related. These results
indicate that it may be stress related because the surge occurs in M and C,
irregardless of lactogenesis.
Thyronine and thyroxin
Plasma T4 was higher -3 wk, while T3 and T4 were higher -1 wk from
parturition (figures 12 and 14). Thyronine and T4 increased in both groups the wk
before calving, and declined the wk after calving except T3 remained elevated in
M. After 3 wk postpartum, both groups were similar in plasma thyroid hormone
concentration. Daily changes in thyroid hormone concentrations were very similar.
Mastectomized cows tended to lag behind C when the hormones spiked around
parturition (figures 13 and 15). Plasma T3 spike occurred -3 d in C, but not until
2 to 3 d from parturition in M. The lag in plasma T4 was only 1 d later for M (C
peaked d, and M peaked 1 d from parturition) than C. The T3 spike was more
pronounced and of greater magnitude in C relative to M, whereas, the opposite was
true for T4.
Blum et al. (3) reported that plasma T3 is highly correlated (r=.72) to energy
and nitrogen balance in sheep. Elevated T3 may contribute to increased blood flow
to the mammary gland (10) as well as increased metabolic activity (T4 is considered
a prohormone of T3)(18). The lag in the thyroid hormone spike in M may be a
result of the lack of need for nutrients and energy needed for milk synthesis. The
fact that the spike still occurs in M indicates that the spike is induced by parturition.
An additional function of thyroid hormones is its synergistic effect it has with PRL
and its ability to stimulate synthesis of a-lactalbumin (a protein subunit of the
lactose synthetase complex)(Stevenson personal communication, 1988).
Prolactin
The weekly trend for plasma PRL is similar in both M and C (figure 16).
Plasma PRL declines from -3 wk to a low at 1 wk from calving for M, while C
doesn't reach its low until 5 wk postpartum. The low at 1 wk postpartum is
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attributed to a lack of milk synthesis in M, while the low in C at 5 wk postpartum
is attributed to weaning the calves, which also stopped milk synthesis. Daily PRL
concentrations were elevated in both groups at -5 d then dropped to a low at -3
and -2 d from calving for M and C, respectively (figure 17). Both groups surged
to a peak at -1 d then declined rapidly to below prepartum levels by 1 and 2 d
from parturition, respectively. Controls had higher levels from 5 to 15 d
postpartum. Similarly, Davis et al. (11) showed PRL started to increase -2 d,
peaked and returned to normal levels by 1 to 2 d from calving. Erb (15) reports
that PRL concentration was similar 3 d before and 1 to 3 d after calving. The PRL
surge is approximately the same magnitude of duration as the length of calving,
therefore PRL may be a stress hormone (Stevenson personal communication, 1988).
Prolactin is influenced by day length, with higher peripheral levels in the
summer (18). The unusually high values (up to 3 times) recorded in the trial are
attributed to the stress of sampling. Samples were taken in a head catch due to the
nature of the cows used. Prolactin is not required after parturition to maintain
lactation, but has been shown by Cowie (9) to enhance lactation. Goats that were
hypophysectomized in mid lactation dropped drastically in milk yield to minimal
levels. Hormone replacement therapy (GCC + T3 + growth hormone) resulted in
28% of normal milk yield. Addition of PRL to the regimen resulted in 100%
recovery in milk yield. There is an increased number of PRL receptors in the
mammary gland after parturition (34). Progesterone has been shown to block PRL
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ability to induce synthesis of PRL receptors (14). This may explain the lower
plasma PRL levels during calving. Akers et al. (1) reported that low PRL levels
impairs cellular function but does not reduce epithelial cell numbers. CB154 (an
ergot alkaloid) was used to block PRL secretion (1). Prolactin is suspected of
having a positive influence on intestinal weight (20). Other functions of PRL
include: regulation of casein mRNA synthesis, by increasing transcription rates and
increasing half-life of casein mRNA in mammary tissue explants from mid pregnant
rats (17,22,27). Goodman et al. (16) concluded that PRL induces synthesis and
release of a-lactalbumin (protein subunit of the rate limiting enzyme for lactose
synthesis). Estrogen and GCC potentiate the lactogenic effect of PRL if
progesterone is absent.
Mammary Minus Jugular Lipoprotein Lipase
Plasma M-JLPL began to increase -1 wk and peaked at 1 wk from
parturition in C (figure 18). Lipase levels remained high through 3 wk after calving,
then dropped by 5 wk in C, possibly due to weaning the calves at 4 wk after birth.
Similar increases (lOx) when MLPL activity were measured at -3 and 2 week from
date of caesarean (essentially start of lactation) (28). Daily levels of plasma M-
JLPL began to rise -1 d, peaked 1 d, and declined slightly 2 d after calving in C
(possibly a result of incomplete milk removal of the newborn calves) (figure 19).
Enzyme activity remained elevated 3 through 15 d after calving. The lack of lipase
activity in M indicates that mammary LPL is independent of direct hormonal control
12
in the bovine. The minimal level of lipolytic activity in M indicates complete
removal of the mammary glands was achieved and further substantiates the use of
plasma M-JLPL activity as an indication of mammary tissue activity.
Adipose Tissue Lipoprotein lipase
Milk LPL activity has been reported to be 12-16 times that of adipose tissue
(26). Zinder et al. (37) indicated that LPL activity increased in the mammary gland
and decreased in adipose tissue when PRL was infused intravenously. Even though
enzyme activity levels are generally much higher in the mammary gland than in
adipose tissue, the mammary gland lacks the response mechanism present in adipose
tissue (26). Three liters of glucose (25% w/v) were infused over a 24 h period to
lactating Holstein cows. Subcutaneous adipose LPL activity increased, while milk
LPL showed an insignificant numerical decrease (25). Figure 20 illustrates that
adipose tissue lipoprotein lipase (ALPL) activity was higher in M than C at -3 wk
from calving. Enzyme activity in M dropped 75% by -1 wk, and stayed low until
1 wk from parturition, then gradually increased through 6 wk. The reduction in
ALPL around parturition in M is a result of hormonal changes associated with
parturition and is independent of mammary gland function. Adipose tissue LPL
activity was minimal beginning -3 wk through 1 wk from parturition, then increased
to M levels by 3 wk. The increase may have been a result of the higher energy diet
fed to all cows after calving. Controls were larger cows and may not have been
receiving sufficient dietary energy prepartum to accumulate adipose tissue like the
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smaller M cows. Tanaka et al. (32) reported increased ALPL in goats when high
concentrate diets were fed. The higher ALPL levels correlates well with the higher
levels of glucose, INS, and GLUCAG measured in M compared to C. Shirley et
al. (28) found a 33% reduction in ALPL with the onset of lactation. Similar results
were recorded with goats when omental fat was sampled -7 to 3 wk from parturition
(7).
CONCLUSIONS
The absence of lactogenesis affected all parameters measured to a degree.
The major effects were recorded in the metabolic hormones (INS and GLUCAG),
in that failure of the milk drain prolonged the parturition peaks. Homeostasis is
tightly controlled and concentration soon returned to prepartum levels. Other
effects that removal of the mammary gland may have had were a decrease in
number of receptors for GCC binding causing higher GCC levels to be recorded
throughout the collection period. Also, mastectomy was responsible for delayed T3
and T4 peaks. Alternately, gland removal had little effect on PRL concentration.
The high levels (up to 3 times normal) may have influenced these results. Finally,
lipase activity responded in a highly predicable fashion.
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Appendix A. Concentration of standard (ug/ml) in heptane).3
Fatty acid ug/ml
C 8 35
CIO 25
C 12 240
C14 85
C 16 185
C 16:1 15
C 17 (internal standard) 275
C18 85
C 18:1 265
C 18:2 50
C 18:3 15
aSupelco, Inc. Bellfonte, PA. (RM-5, RM-6, and C 17:0).
Appendix B. Composition of the TG premix was:
-0.64 ml glycerol tri(9,10 (n) - 3H)oleatea(Amersham TRA 191. >99% TG.
5mCi/25 ml hexane) This was diluted to achieve 88x10* DPM. Radioactive decay
was calculated based on age of purchased stock and its half-life. This was stored
at -20°C under N2.
-1.00 ml triolein (Sigma T7140. MW=885.4. Approx. 99%) Purchased stock
was diluted with toluene to yield 150mM solution. This was stored at 4-6°C under
N2-
Composition of the fatty acid (FA) premix was:
-0.74 ml (9,10(n) -3H) oleic acida(Amersham TRK 140. 5mCi/.25 ml hexane)
This was diluted to achieve 3.52X106 DPM. Radioactive decay was calculated based
on age of purchased stock and its half-life. This was stored at -20°C under N2.
-1.00 ml triolein
aBoth the TG and FA radiolabeled standards were purified (Carroll, 1961) with a
silica gel column (Baker 7086. J.T. Baker Chemical Company, Phillipsburg, NJ
08865). Columns were conditioned with 3-4 ml toluene. Columns were loaded
with 3 ml (1 ml x 3) of respective standard. The eluting solvents were: toluene
(1 ml x 3), 20% ether in hexane (1 ml x 5), 2% methanol in ether (1 ml x 5), and
ethyl acetate (1 ml x 5). 90.81 and 94.86% of total TG and FA radioactivity was
recovered in 20% ether in hexane and 2% methanol in ether eluent, respectively.
Both premixes were evaporated under N2. Working premixes were made by
adding:
-2.5 ml heat denatured serum (HDS). Serum from a lactating cow (#923)
was heated at 56°C for 1 h. Serum was centrifuged at 48,000 x g for 20 min.
Supranatant was stored at -80°C.
--8.1 ml 8% BSA, .24 M tris, .15 M NaCl, pH 8.6
-0.9 ml 1% triton X-100
Premixes were placed on ice and sonicated (power setting = 4) 4 x 1 min with 1
min intervals for cooling. Premixes were stable on ice for 6-12 h (25).
Appendix C. Calculations used in LPL assay.
1) FA recovery factor =
(DPM FA premix standard x 10)/(DPM FA recovery)
2) nmol FA/DPM =
(FA recovery factor)x(391.3 nmol FA/10 ul premix^
(DPM of TG premix standard)
3) nmol FA/tube =
((DPM/tube) - (DPM/enzyme blank)) x (nmol FA/DPM)
Appendix D. Procedure for preparing adipose tissue for subsequent protein and
LPL analysis.
1. Weigh and record approximately 1-3 g of frozen adipose
tissue into 50 ml
polyethelene centrifuge tube.
2. Keep sample frozen until ready for homogenation.
3. Add approximately 3X ml (1:3 - W:V - Adipose tissue:0.15M
KC1) of 0.15M KC1 (0-5°C) to tube and homogenize
(Polytron) for 30-45 s in ice water.
4. Centrifuge at 900 x g for 10 min at 4°C.
5. Pour fluid through 2 layers of cheesecloth.
6. Freeze filtrate until needed for protein or LPL determination.
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ABSTRACT
Various dosages (0, 150, 300, 450 mg/d) of monensin supplementation were
fed to two Holstein cows (trial #1). Changes were recorded in most of the
economically important parameter after the initial (150 mg) level was fed. Milk
yield increased 6.3%, while fat content and yield decreased 8.6% and 2.8%,
respectively. Protein yield decreased 14.9% in early lactation due to monensin and
did not change with monensin supplementation in late lactation. As a result of trial
#1, four of eight Holsteins at peak lactation (35.6 d postpartum) were
supplemented with 200 mg/d of monensin for 3 wk. Net results of monensin
supplementation (average of 150 to 450 mg level) include: +7.4% milk yield, +3.6%
fat corrected milk, -8.5% fat content, -1.1% fat yield, +0.2% protein content, and
+ 10.1% protein yield. Dry matter intake decreased 1.8%, while feed efficiency
increased 5.7%. Milk fatty acid composition and plasma lipoprotein lipase changes
reflected stage of lactation shifts and were not effected by monensin in either trial.
Ruminal propionate and isobutyrate increased (16.4%, 11.1%, 10.7%, and 8.1% in
exp. 1 and 2, respectively) with monensin supplementation.
Mastectomies were performed on eleven beef cows to determine the
mammary gland's contribution to homeorhesis during parturition. Fourteen normal
beef cows served as controls (C). Plasma glucose tended to increase to a peak
earlier in the mastectomized (M) group, and did not decline to prepartal levels as
soon as C. Higher glucose levels in M resulted from higher glucagon levels before
calving, and caused increased insulin levels after calving. Plasma Cortisol was
elevated in M throughout the trial, with inconsistent surges -4 to 5 d from calving
in both groups. This suggests that the surges are stress related responses of
parturition. Thyroid hormones followed similar patterns between M and C, but the
peak associated with parturition was delayed 1 to 3 d in M. This indicates that the
mammary gland has a secondary effect on the timing of thyroid hormone release.
A plasma prolactin surge at parturition was recorded in both groups and decreased
to below prepartal levels in M and C. Mammary lipoprotein lipase activity
drastically increased 1 d prepartum and peaked 2 wk postpartum in C, while M
remained at undetectable levels after calving. Mammary lipase is independent of
direct hormonal control. Adipose tissue lipoprotein lipase declined as a result of
parturition in M, indicating peripartal hormonal control. Adipose tissue lipase
activity began increasing from minimal levels 3 wk after calving as a result of
increased dietary energy intake.
